🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We also heard a fantastic keynote from Mark Foundation Scientific Advisory Committee member and grantee Charles Swanton, who presented findings from his ASPIRE Award work showing how exposure to air pollution can drive lung cancer development. #EACR2025 themarkfoundation.org/portfolio/tumo…

Exciting new paper in J. Am. Chem. Soc. from Mark Foundation Scientific Advisory Committee member and ASPIRE Awardee Dan Nomura! This work could ultimately lead to new avenues for #prostatecancer treatment.

It's 102°F/39°C in New Haven—but 30 international experts have braved the heatwave to join us at Yale School of Medicine for a 3-day workshop on chromosomal instability in cancer. Thank you to our workshop organizers, Roel Verhaak, Florian Markowetz, & Aurelie Ernst!

Amazing time at the chromosomal instability workshop (thank you The Mark Foundation for Cancer Research !). So lucky to be a part of this incredible community. The science discussed here is just 🤯.

The Mark Foundation for Cancer Research is now offering $3M in funding over 3 years to fund basic, translational and clinical projects focused on upper GI, GBM, TNBC and #pancreaticcancer. Letters of intent are due September 3rd. Learn more: themarkfoundation.org/endeavor/

This study describes one of the most amazing IFN-stimulated genes (ISGs) I have ever learned about!! Congrats meg clark, Jorge Henao Mejia, and team! Your work is amazing. Thanks also to The Mark Foundation for Cancer Research for supporting this project as part of the Mark Foundation Center at Penn.

Exciting progress in cancer treatment! 🎉Our portfolio company Interius BioTherapeutics is developing a novel lentiviral platform for in vivo CAR therapy. The approach could offer patients an “off the shelf” treatment option—& it doesn’t require pre-treatment chemo. cell.com/molecular-ther…

Congratulations to 2020 Emerging Leader Award winner Jeff Tyner, who has been named George Ettelson Endowed Professor of Acute Myeloid Leukemia Research at OHSU News! OHSU Knight Cancer Institute news.ohsu.edu/2025/06/30/ohs…

Could early-life mutagenic exposure to colibactin-producing bacteria be a driver in rising rates of #colorectalcancer? IARC-Mark Foundation Postdoctoral Fellow Wellington Oliveira dos Santos highlights a potential link in a new nature paper. nature.com/articles/s4158…

Congratulation to all winners of the 36th Pezcoller Symposium! 🧪🏆 Best Poster Lectures, Pezcoller-Begnudelli Awards, Best Abstract Awards and EMBO Poster Prize 🏅🎉 Thank to support of EACR, AACR, The Mark Foundation for Cancer Research and EMBO